A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Clin Gastroenterol Hepatol
; 12(1): 64-71, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-23872668
Palavras-chave
AQoL; Autoimmune; C-reactive protein; CD; CDAI; CDEIS; CMV; CRP; Cellular Therapy; Crohn's disease; Crohn's disease activity index; Crohn's disease endoscopic index of severity; GVHD; IBDQ; Immune Response; Inflammation; Intestine; MSC; assessment of quality of life; cytomegalovirus; graft-versus-host disease; inflammatory bowel disease questionnaire; mesenchymal stromal cell
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transplante Homólogo
/
Doença de Crohn
/
Transplante de Células
/
Células-Tronco Mesenquimais
Tipo de estudo:
Clinical_trials
Aspecto:
Patient_preference
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Gastroenterol Hepatol
Ano de publicação:
2014
Tipo de documento:
Article